Pharmaceuticals

Over-The-Counter Drug Market size to grow by USD 58.54 billion from 2022 to 2027, Abbott Laboratories and Achelios Therapeutics Inc. emerge as key contributors to market growth

by

NEW YORK, May 17, 2023 /PRNewswire/ — The over-the-counter drug market size is set to grow by USD 58.54 billion from 2022 to 2027. The market is expected to register progress at a CAGR of 6.53%, according to Technavio’s latest market research report estimates. With a focus on identifying dominant industry influencers, Technavio’s reports present a detailed study by … Read more

Evofem Biosciences Announces 1-for-125 Reverse Stock Split

by

— CUSIP number for Evofem will change to 30048L302 on May 18, 2023 — — Ticker symbol will change to “EVFMD” for 20 business days, then revert to “EVFM” — SAN DIEGO, May 17, 2023 /PRNewswire/ — Evofem Biosciences, Inc., (OTCQB: EVFM) (the “Company”) today announced a 1-for-125 reverse stock split of the Company’s common stock, … Read more

Antengene Announces Clearance of U.S. IND for the Phase I Trial of First-in-Class Anti-CD24 Monoclonal Antibody ATG-031

by

–  ATG-031, discovered and developed in-house by Antengene, is the world’s first anti-CD24 antibody to advance to the clinic in oncology and Antengene’s third drug candidate to enter clinical studies in the U.S. –  The Phase I “PERFORM” study will evaluate the safety and tolerability, pharmacology, immunogenicity, and preliminary efficacy of ATG-031 in patients with … Read more

Look at a Selection of over 4000 Brands

by

DUBLIN, May 17, 2023 /PRNewswire/ — The “2023 Weight Management – Douyin, China E-commerce Market Data Subscription” database has been added to  ResearchAndMarkets.com’s offering. This database subscription gives you all the information you need on the market for weight management supplements in the Chinese market, as measured on the Douyin platform. The data subscription service … Read more

PTC Therapeutics Announces APHENITY Trial Achieved Primary Endpoint with Sepiapterin in PKU Patients

by

– Highly statistically significant and clinically meaningful results – – 63% mean blood Phe reduction in primary analysis population (p<0.0001) – – Conference call and webcast to be held at 8:00 AM EDT – SOUTH PLAINFIELD, N.J., May 17, 2023 /PRNewswire/ — PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that the primary endpoint was achieved in … Read more

Growing Focus on Drug Discovery Boosts Sector

by

DUBLIN, May 17, 2023 /PRNewswire/ — The “Genetic Toxicology Testing Market – Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F Segmented by Component (Reagents & Consumables, Assays, Services), By Type (In Vitro v/s In Vivo), By Application, By Region” report has been added to ResearchAndMarkets.com’s offering. Global genetic toxicology testing market is anticipated to witness impressive … Read more

Judge Appoints Four Attorneys to Lead 77,000 Zantac Cancer Cases in Delaware

by

WILMINGTON, Del., May 17, 2023 /PRNewswire/ — Wisner Baum managing partner R. Brent Wisner will be co-lead trial counsel in the Zantac (Ranitidine) Products Liability litigation (Civil Action No. N22C-09-101 ZAN) in Delaware Superior Court. Judge Appoints Four Attorneys to Lead 77,000 Zantac Cancer Cases in Delaware Judge Vivian L. Medinilla named Wisner and three others … Read more

New Menarini Silicon Biosystems partnership with Alivio Health expands patient access to CELLSEARCH® liquid biopsy tests

by

Menarini Silicon Biosystems just signed a partnership with Alivio Health to provide preferred access, to their clients and members, to the minimally invasive CELLSEARCH® CTC tests so that more cancer patients may benefit from real-time information on disease status and response to therapy. BOLOGNA, Italy and HUNTINGDON VALLEY, Pa., May 17, 2023 /PRNewswire/ — Menarini … Read more

CASI PHARMACEUTICALS ANNOUNCES FIRST QUARTER 2023 FINANCIAL RESULTS

by

BEIJING, May 17, 2023 /PRNewswire/ — CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a Cayman Islands incorporated biopharmaceutical company focused on developing and commercializing innovative therapeutics and pharmaceutical products, today reported financial results for the three months ended March 31, 2023. Wei-Wu He, Ph.D., CASI’s Chairman and Chief Executive Officer, commented, “Revenue for EVOMELA® was $8.3 million … Read more

Platelet Rich Plasma Market to Showcase Excellent Growth- Brandessence Market Research

by

LONDON, May 17, 2023 /PRNewswire/ — Platelet-rich plasma (PRP) is revolutionizing the field of regenerative medicine. Derived from a patient’s own blood, this golden elixir has the potential to heal and rejuvenate damaged tissues. PRP is enriched with a concentrated dose of platelets along with bioactive proteins and acts as a powerful stimulant, triggering natural repair … Read more